Serena Williams, one of the most successful athletes of all time, has spoken out about using weight loss drugs - she says, to ...

Lil Terrio has given fans a major life update and advice on how to push through adversity. On Thursday, the 17-year-old ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

Demand for Novo Nordisk A/S’s weight-loss blockbuster Wegovy is getting a boost in the UK from an unexpected corner: ...

Sara H. Jodka of Dickinson Wright PLLC discusses the legal landscape surrounding GLP-1 programs for weight loss, in light of ...

U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

A new European obesity framework adds waist-to-height ratio and comorbidities to BMI assessment. Could this help identify ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

For patients with inflammatory bowel disease and obesity, bariatric surgery is associated with improved inflammatory bowel ...

Obesity before pregnancy, not just during, may shape a child’s brain and raise the risk of autism spectrum disorder, a new ...

Researchers assessed how obesity influences spinal radiographic features among patients with metabolic syndrome.